Eargo to complete a 1-for-20 reverse stock split

San jose, calif., jan. 11, 2023 (globe newswire) -- eargo, inc. (“eargo” or the “company”) (nasdaq: ear), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that its board of directors has approved a 1-for-20 reverse stock split of the company's common stock. the company's common stock is expected to begin trading on a split-adjusted basis when the markets open on wednesday, january 18, 2023, under the existing trading symbol “ear” and a new cusip number: 270087208.
EAR Ratings Summary
EAR Quant Ranking